PubMed · 2014 · 43 citations · 21 references
Life SciencesMolecular BiologyOncologyCell SignalingMolecular OncologySignal TransductionCancer Cell SignalingGrowth Factor SignalingNuclear Receptor SignalingNuclear ReceptorsOncogenic Signaling PathwaysSignal Transduction In CancerEpidermal Growth Factor Receptor SignalingNrf2 Pathway ActivationNrf2 Signaling PathwayNrf2-mediated ResponsesNuclear Translocation Of Transcription FactorsOxidative Stress InjuryOxidative Stress InteractionsTherapeutic Resistance Mechanisms
Nuclear translocation of EGFR has been shown to be important for tumor cell growth, survival, and therapeutic resistance. Previously, we detected the association of EGFR with Keap1 in the nucleus. Keap1 is a Kelch-like ECH-associated protein, which plays an important role in cellular response to chemical and oxidative stress by regulating Nrf2 protein stability and nuclear translocation. In this study, we investigate the role of EGFR in regulating Keap1/Nrf2 cascade in the nucleus and provide evidence to show that nuclear EGFR interacts with and phosphorylates nuclear Keap1 to reduce its nuclear protein level. The reduction of nuclear Keap1 consequently stabilizes nuclear Nrf2 and increases its transcriptional activity in cancer cells, which contributes to tumor cell resistance to chemotherapy.
21
Nrf2 enhances resistance of cancer cells to chemotherapeutic drugs, the dark side of Nrf2
X.-J. Wang, Zheng Sun, Nicole Villeneuve et al. · Carcinogenesis · 2008 · 842 citations · Full text
Nrf2 Enhances Cell Proliferation and Resistance to Anticancer Drugs in Human Lung Cancer
Shinsuke Homma, Yukio Ishii, Yuko Morishima et al. · Clinical Cancer Research · 2009 · 417 citations
Medicine, Oncology, Pharmacology +14